ShockWave Medical, Inc. (SWAV) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Devices secteur d'activité. Le siège social de l'entreprise est situé à Santa Clara, CA, United States. Le PDG actuel est Douglas E. Godshall.
SWAV a date d'introduction en bourse 2019-03-07, 1,468 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $12.57B.
ShockWave Medical, Inc. is a medical device company that develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases globally. The company's product portfolio includes M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. ShockWave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists through a network of sales representatives, managers, and distributors. Founded in 2009 and headquartered in Santa Clara, California, the company addresses critical treatment needs across multiple vascular intervention markets.
